Annual EBIT:
-$451.22M-$90.30M(-25.02%)Summary
- As of today, MDGL annual earnings before interest & taxes is -$451.22 million, with the most recent change of -$90.30 million (-25.02%) on December 31, 2024.
- During the last 3 years, MDGL annual EBIT has fallen by -$209.38 million (-86.57%).
- MDGL annual EBIT is now -660.24% below its all-time high of $80.54 million, reached on December 31, 2009.
Performance
MDGL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$39.02M+$30.92M(+44.21%)Summary
- As of today, MDGL quarterly earnings before interest & taxes is -$39.02 million, with the most recent change of +$30.92 million (+44.21%) on June 30, 2025.
- Over the past year, MDGL quarterly EBIT has increased by +$109.30 million (+73.69%).
- MDGL quarterly EBIT is now -133.02% below its all-time high of $118.17 million, reached on September 30, 2009.
Performance
MDGL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$268.16M+$109.30M(+28.96%)Summary
- As of today, MDGL TTM earnings before interest & taxes is -$268.16 million, with the most recent change of +$109.30 million (+28.96%) on June 30, 2025.
- Over the past year, MDGL TTM EBIT has increased by +$227.32 million (+45.88%).
- MDGL TTM EBIT is now -386.86% below its all-time high of $93.48 million, reached on March 31, 2010.
Performance
MDGL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MDGL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -25.0% | +73.7% | +45.9% |
| 3Y3 Years | -86.6% | +44.2% | -5.1% |
| 5Y5 Years | -375.1% | +22.5% | -51.4% |
MDGL EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -86.6% | at low | at high | +73.7% | at high | +46.7% |
| 5Y | 5-Year | -375.1% | at low | at high | +73.7% | -51.4% | +46.7% |
| All-Time | All-Time | -660.2% | at low | -133.0% | +73.7% | -386.9% | +46.7% |
MDGL EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$39.02M(+44.2%) | -$268.16M(+29.0%) |
| Mar 2025 | - | -$69.94M(-25.1%) | -$377.46M(+16.3%) |
| Dec 2024 | -$451.22M(-25.0%) | -$55.92M(+45.9%) | -$451.22M(+10.4%) |
| Sep 2024 | - | -$103.28M(+30.4%) | -$503.53M(-1.6%) |
| Jun 2024 | - | -$148.31M(-3.2%) | -$495.48M(-15.2%) |
| Mar 2024 | - | -$143.70M(-32.8%) | -$430.06M(-19.2%) |
| Dec 2023 | -$360.92M(-23.9%) | -$108.22M(-13.6%) | -$360.92M(-7.1%) |
| Sep 2023 | - | -$95.24M(-14.9%) | -$336.92M(-4.8%) |
| Jun 2023 | - | -$82.90M(-11.2%) | -$321.38M(-4.2%) |
| Mar 2023 | - | -$74.56M(+11.5%) | -$308.43M(-5.8%) |
| Dec 2022 | -$291.39M(-20.5%) | -$84.22M(-5.7%) | -$291.39M(-7.2%) |
| Sep 2022 | - | -$79.69M(-13.9%) | -$271.71M(-6.5%) |
| Jun 2022 | - | -$69.95M(-21.6%) | -$255.12M(-3.4%) |
| Mar 2022 | - | -$57.52M(+10.9%) | -$246.82M(-1.9%) |
| Dec 2021 | -$241.85M(-17.0%) | -$64.55M(-2.3%) | -$242.28M(-2.1%) |
| Sep 2021 | - | -$63.10M(-2.4%) | -$237.28M(-1.9%) |
| Jun 2021 | - | -$61.65M(-16.4%) | -$232.97M(-5.1%) |
| Mar 2021 | - | -$52.98M(+11.0%) | -$221.65M(-7.2%) |
| Dec 2020 | -$206.67M(-117.6%) | -$59.55M(-1.3%) | -$206.67M(-16.7%) |
| Sep 2020 | - | -$58.79M(-16.8%) | -$177.07M(-24.3%) |
| Jun 2020 | - | -$50.33M(-32.4%) | -$142.48M(-24.0%) |
| Mar 2020 | - | -$38.01M(-26.9%) | -$114.86M(-20.9%) |
| Dec 2019 | -$94.97M(-133.4%) | -$29.95M(-23.8%) | -$94.97M(-19.5%) |
| Sep 2019 | - | -$24.20M(-6.6%) | -$79.47M(-19.3%) |
| Jun 2019 | - | -$22.70M(-25.3%) | -$66.61M(-28.8%) |
| Mar 2019 | - | -$18.12M(-25.4%) | -$51.73M(-27.2%) |
| Dec 2018 | -$40.68M(-26.9%) | -$14.45M(-27.5%) | -$40.68M(-15.8%) |
| Sep 2018 | - | -$11.33M(-44.8%) | -$35.14M(-8.3%) |
| Jun 2018 | - | -$7.83M(-10.7%) | -$32.44M(+1.9%) |
| Mar 2018 | - | -$7.07M(+20.7%) | -$33.06M(-3.1%) |
| Dec 2017 | -$32.06M(-27.4%) | -$8.91M(-3.2%) | -$32.06M(-3.8%) |
| Sep 2017 | - | -$8.64M(-2.3%) | -$30.90M(+14.9%) |
| Jun 2017 | - | -$8.44M(-38.9%) | -$36.31M(-19.0%) |
| Mar 2017 | - | -$6.08M(+21.6%) | -$30.51M(-21.2%) |
| Dec 2016 | -$25.18M(-678.7%) | -$7.75M(+44.8%) | -$25.18M(-37.2%) |
| Sep 2016 | - | -$14.05M(-432.4%) | -$18.34M(-254.5%) |
| Jun 2016 | - | -$2.64M(-257.6%) | -$5.18M(+76.5%) |
| Mar 2016 | - | -$738.00K(+19.6%) | -$22.04M(+47.1%) |
| Dec 2015 | -$3.23M(+96.1%) | -$918.40K(-4.4%) | -$41.63M(+31.3%) |
| Sep 2015 | - | -$880.00K(+95.5%) | -$60.61M(+23.5%) |
| Jun 2015 | - | -$19.50M(+4.1%) | -$79.18M(+2.7%) |
| Mar 2015 | - | -$20.33M(-2.2%) | -$81.38M(+3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | -$83.95M(+4.1%) | -$19.89M(-2.3%) | -$83.95M(+4.1%) |
| Sep 2014 | - | -$19.45M(+10.4%) | -$87.50M(+2.6%) |
| Jun 2014 | - | -$21.70M(+5.3%) | -$89.85M(+0.4%) |
| Mar 2014 | - | -$22.91M(+2.3%) | -$90.21M(-3.0%) |
| Dec 2013 | -$87.56M(-43.7%) | -$23.44M(-7.6%) | -$87.56M(-7.0%) |
| Sep 2013 | - | -$21.79M(+1.2%) | -$81.82M(-9.7%) |
| Jun 2013 | - | -$22.06M(-8.9%) | -$74.56M(-11.9%) |
| Mar 2013 | - | -$20.26M(-14.4%) | -$66.63M(-9.3%) |
| Dec 2012 | -$60.94M(-34.1%) | -$17.70M(-21.8%) | -$60.94M(-14.0%) |
| Sep 2012 | - | -$14.54M(-2.9%) | -$53.48M(-4.5%) |
| Jun 2012 | - | -$14.13M(+3.0%) | -$51.16M(-4.3%) |
| Mar 2012 | - | -$14.56M(-42.3%) | -$49.03M(-7.9%) |
| Dec 2011 | -$45.43M(-23.1%) | -$10.24M(+16.2%) | -$45.43M(-4.3%) |
| Sep 2011 | - | -$12.22M(-1.7%) | -$43.56M(-4.8%) |
| Jun 2011 | - | -$12.01M(-9.5%) | -$41.57M(-7.7%) |
| Mar 2011 | - | -$10.97M(-31.1%) | -$38.61M(-4.6%) |
| Dec 2010 | -$36.90M(-145.8%) | -$8.37M(+18.2%) | -$36.90M(-3.9%) |
| Sep 2010 | - | -$10.23M(-13.1%) | -$35.51M(-138.2%) |
| Jun 2010 | - | -$9.04M(+2.3%) | $92.89M(-0.6%) |
| Mar 2010 | - | -$9.26M(-32.6%) | $93.48M(+16.1%) |
| Dec 2009 | $80.54M(+185.9%) | -$6.98M(-105.9%) | $80.54M(+30.6%) |
| Sep 2009 | - | $118.17M(+1498.0%) | $61.66M(+174.3%) |
| Jun 2009 | - | -$8.45M(+61.9%) | -$82.97M(+14.9%) |
| Mar 2009 | - | -$22.20M(+14.2%) | -$97.46M(-4.0%) |
| Dec 2008 | -$93.71M(-41.5%) | -$25.86M(+2.2%) | -$93.71M(-11.3%) |
| Sep 2008 | - | -$26.45M(-15.3%) | -$84.19M(-15.1%) |
| Jun 2008 | - | -$22.95M(-24.4%) | -$73.13M(-8.1%) |
| Mar 2008 | - | -$18.45M(-12.9%) | -$67.65M(-2.2%) |
| Dec 2007 | -$66.22M(-11.9%) | -$16.34M(-6.2%) | -$66.22M(-5.3%) |
| Sep 2007 | - | -$15.39M(+11.9%) | -$62.88M(-1.3%) |
| Jun 2007 | - | -$17.47M(-2.7%) | -$62.06M(-4.3%) |
| Mar 2007 | - | -$17.01M(-30.8%) | -$59.52M(-3.6%) |
| Dec 2006 | -$59.15M(+16.9%) | -$13.01M(+10.8%) | -$57.44M(+4.2%) |
| Sep 2006 | - | -$14.58M(+2.4%) | -$59.92M(-32.1%) |
| Jun 2006 | - | -$14.93M(0.0%) | -$45.35M(-49.1%) |
| Mar 2006 | - | -$14.93M(+3.6%) | -$30.42M(+10.5%) |
| Dec 2005 | -$71.18M(-57.0%) | -$15.49M(+16.3%) | -$33.99M(-83.7%) |
| Mar 2005 | - | -$18.50M(-239.3%) | -$18.50M(-239.3%) |
| Dec 2004 | -$45.35M(-60.3%) | - | - |
| Mar 2004 | - | -$5.45M | -$5.45M |
| Dec 2003 | -$28.29M(-288.0%) | - | - |
| Dec 2002 | -$7.29M(-1718.5%) | - | - |
| Dec 2001 | -$401.00K | - | - |
FAQ
- What is Madrigal Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Madrigal Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of MDGL is -$451.22M
What is the all-time high annual EBIT for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is $80.54M
What is Madrigal Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, MDGL annual earnings before interest & taxes has changed by -$90.30M (-25.02%)
What is Madrigal Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of MDGL is -$39.02M
What is the all-time high quarterly EBIT for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $118.17M
What is Madrigal Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, MDGL quarterly earnings before interest & taxes has changed by +$109.30M (+73.69%)
What is Madrigal Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of MDGL is -$268.16M
What is the all-time high TTM EBIT for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is $93.48M
What is Madrigal Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, MDGL TTM earnings before interest & taxes has changed by +$227.32M (+45.88%)